Redirected Auto T Cells for Advanced Myeloma

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Adaptimmune
ClinicalTrials.gov Identifier:
NCT01352286
First received: May 4, 2011
Last updated: July 29, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2031
  Estimated Primary Completion Date: April 2021 (Final data collection date for primary outcome measure)